NEOTACK Tablet

Ranitidine is contraindicated for patients known to have hypersensitivity to the drug or any of the ingredients.

Headache, malaise, dizziness, constipation, nausea, abdominal pain and rash may occur. Mental confusion and hallucination have occurred in geriatric patients during ranitidine therapy.

Animal studies have not shown any harmful effects on the fetus when administered to pregnant women. However, it crosses the placenta, so the drug should be given in this context only when absolutely necessary. Ranitidine secreted into breast milk and therefore may affect the nursing infant.

Neotack is a histamine H2-receptor antagonist. As a result of its H2-receptor blocking action Neotack promotes rapid and effective ulcer healing with sustained pain relief, both day and night by reduction of gastric acid output. After oral administration Ranitidine is rapidly absorbed from the GI tract.